Heinz Hillen on Picking Through the Rubble, Field Tries to Salvage BACE Inhibitors
COMMENT Once we allocate a physiological function for nascent Aβ monomer levels at synaptic sites, current clinical results around BACE inhibitors as well as γ-secretase inhibitors and pan-Aβ immunotherapies become explainable (Hillen, 2019). Lowering Aβ producti